Cargando…
Unique Phenotypes With Corresponding Pathology in Late-Onset Hereditary Transthyretin Amyloidosis of A97S vs. V30M
OBJECTIVE: Hereditary transthyretin amyloidosis (ATTRv) encompasses different phenotypes among various genotypes. The analysis of the natural history and risk factors of faster progression in different genotypes would refine the treatment strategy. METHODS: The clinical manifestations of ATTRv from...
Autores principales: | Hsueh, Hsueh-Wen, Chao, Chi-Chao, Chang, Koping, Jeng, Yung-Ming, Katsuno, Masahisa, Koike, Haruki, Hsieh, Sung-Tsang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8826435/ https://www.ncbi.nlm.nih.gov/pubmed/35153720 http://dx.doi.org/10.3389/fnagi.2021.786322 |
Ejemplares similares
-
Widespread Cardiac and Vasomotor Autonomic Dysfunction in Non-Val30Met Hereditary Transthyretin Amyloidosis
por: Koike, Haruki, et al.
Publicado: (2018) -
Multidisciplinary Approaches for Transthyretin Amyloidosis
por: Koike, Haruki, et al.
Publicado: (2021) -
Ultrastructure in Transthyretin Amyloidosis: From Pathophysiology to Therapeutic Insights
por: Koike, Haruki, et al.
Publicado: (2019) -
Transthyretin Amyloidosis: Update on the Clinical Spectrum, Pathogenesis, and Disease-Modifying Therapies
por: Koike, Haruki, et al.
Publicado: (2020) -
Tafamidis decreased cardiac amyloidosis deposition in patients with Ala97Ser hereditary transthyretin cardiomyopathy: a 12-month follow-up cohort study
por: Tsai, Cheng-Hsuan, et al.
Publicado: (2023)